Gimeno, R., Ribas-Llauradó, C., Pesqué, D., Andrades, E., Cenni, B., Ambros, B., . . . Giménez Arnau, A. M. (2023). Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response.
Citación estilo ChicagoGimeno, Ramón, Clara Ribas-Llauradó, David Pesqué, Evelyn Andrades, Bruno Cenni, Barbara Ambros, Ramon Maria Pujol Vallverdú, y Anna Maria Giménez Arnau. Remibrutinib Inhibits Hives Effector Cells Stimulated By Serum From Chronic Urticaria Patients Independently of FcεR1 Expression Level and Omalizumab Clinical Response. 2023.
Cita MLAGimeno, Ramón, et al. Remibrutinib Inhibits Hives Effector Cells Stimulated By Serum From Chronic Urticaria Patients Independently of FcεR1 Expression Level and Omalizumab Clinical Response. 2023.